At least seven people in five U.S. states were infected with the novel coronavirus weeks before those states reported their first cases, a new government study...
As the field for monoclonal antibody treatments of Covid-19 grows more crowded, AstraZeneca has announced a study of its own cocktail AZD7442 did not meet its...
AZ’s COVID jab tackles delta variant, but antibody fails clinical trial appeared first on .
Novavax Inc. said vaccine efficacy appeared to be preserved in those receiving an approved influenza vaccine along with the company's Covid-19 vaccine candidate compared to those...
PREVENT-19 met a key exploratory endpoint of the study by showing 93.2% efficacy against both “variants of concern” (VoC) and “variants of interest (VoI). Variant data...
Upon regulatory approvals, Novavax said, it is on course to reach manufacturing capacity of 100 million doses per month by the end of the third quarter...
Gene expression patterns associated with pandemic viral infections provide a map to help define patients’ immune responses, measure disease severity, predict outcomes and test therapies —...
Public Health Officials Stumped As Southern States' Vaccination Rate Continues To Drag Less than a week ago, we reported that the US COVID-19 vaccination scheme had...
Check out these biotech players under the microscope now. The post Best Stocks To Invest In Right Now? 3 Biotech Stocks To Know appeared first on...
Scientists now understand the mechanism that leads to platelet activation and clotting Credit: McMaster University Hamilton, ON (June 9, 2021) – A new lifesaving treatment for...
Merck and Pfizer have been locked in a yearslong battle for a next-gen pneumococcal vaccine winner, with the latter looking to one-up — or should we...
An experimental new type of antibody drug from IGM Bioscience Inc. may be more potent at inhibiting the coronavirus and its variants than antibody therapies currently...
Which biotech penny stocks are on your watchlist as Covid comes to an end? The post Top Biotech Penny Stocks to Buy? Check These Small-Caps Out...
- by New Deal democratThe drive towards “herd immunity” via vaccination has slowed to a crawl. The slowing is almost entirely driven by Trump-voting States in...
Unthinkable Thoughts... Authored by Josh Mitteldorf, This essay is inspired by Dr Mercola’s announcement last week that [May] (reading between the lines) his life and his family’s have...
Fauci's NIH Funded Wuhan Military Scientist Who Died Mysteriously After Filing COVID Vaccine Patent As we move further down the rabbit hole of exactly what in...
Enzolytics, Inc. (ENZC) is making a powerful move up the charts in recent days since a brief dip below the $0.10 mark. ENZC is a major...
Why Is There Such Reluctance To Discuss Natural Immunity? Authored by Jon Sanders via The American Institute for Economic Research, If you’re among those of us...
The U.S. health regulator authorized a lower dose of Regeneron Pharmaceuticals' Covid-19 antibody cocktail that can be given by injection, a move that could ease logistical...
Hundreds of thousands of Canadians got a shot of AstraZeneca's COVID-19 vaccine for their first dose. They now have a choice for their second dose: AstraZeneca...
The FDA on Friday authorized a new, lower-dose version of Regeneron’s Covid-19 monoclonal antibody cocktail for those with Covid-19 who are at high-risk of progressing to...
Making a penny stocks watchlist in 2021? Check these 4 small-caps out The post 4 Hot Penny Stocks to Watch in 2021, Are They on Your...
Current guidelines for screening U.S. blood donors for symptoms of COVID-19 and for a history of recent infections are effectively protecting the blood supply from contamination...
A more coordinated effort by scientists, stakeholders and community members will be required to stop the next deadly virus that's already circulating in our midst.
A study out of Washington University School of Medicine in St. Louis found that months after recovering from mild Covid-19, patients maintained antibodies against the SARS-CoV-2...
France's Sanofi and Britain's GlaxoSmithKline launched a late-stage human trial for a recombinant Covid-19 vaccine candidate on May 27 which they hope to get approved by...
GlaxoSmithKline’s COVID-19 drive has advanced on two fronts, with the start of phase 3 trials of its Sanofi-partnered The post GSK, Sanofi eye Q4 approval as...
A digital tool that will make it cheaper, safer and faster to develop new medicines is being rolled out by scientists from the University of Bath...
The genetics industry provides data that life science companies need to make new products. Here's a look at the largest genetics stocks. The post 5 Largest Genetics...
The U.S. Food and Drug Administration gave an emergency use authorization to the antibody treatment developed by Vir Biotechnology and GlaxoSmithKline for treating mild-to-moderate Covid-19 in...